SEMAGLUTIDE IMPROVES LIVER ENZYMES AND FATTY LIVER INDEX IN PATIENTS WITH OBESITY AND CARDIOVASCULAR DISEASE - RESULTS FROM THE SELECT TRIAL

被引：0
|
作者：
Meyhoefer, Sebastian [1 ]
Cariou, Bertrand [2 ]
Cercato, Cintia [3 ]
Colhoun, Helen [4 ]
Deanfield, John [5 ]
Kjaer, Mette Skalshoi [6 ]
Jeppesen, Ole [6 ]
Lincoff, A. Michael [7 ,8 ]
Lingvay, Ildiko [9 ]
Newsome, Phillip [10 ,11 ]
Nicholls, Stephen [12 ]
Pelaez, Maria De Los Angeles Quiroga [6 ]
Santini, Ferruccio [13 ]
Sanyal, Arun [14 ]
Kahn, Steven [15 ,16 ]
机构：
[1] Novo Nordisk Pharma GmbH, Clin Med & Regulatory, Mainz, Germany
[2] Nantes Univ, CHU Nantes, CNRS, INSERM,Inst Thorax, Nantes, France
[3] Univ Sao Paulo, Hosp Clin, Dept Endocrinol, Obes Unit, Sao Paulo, Brazil
[4] Univ Edinburgh, Inst Genet & Canc, Edinburgh, Midlothian, Scotland
[5] UCL, Inst Cardiovasc Sci, London, England
[6] Novo Nordisk AS, Soborg, Denmark
[7] Cleveland Clin, Cleveland, OH 44106 USA
[8] Case Western Reserve Univ, Lerner Coll Med, Cleveland, OH 44106 USA
[9] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[10] Kings Coll London, Inst Hepatol, London, England
[11] Kings Coll Hosp London, London, England
[12] Monash Univ, Victorian Heart Inst, Melbourne, Vic, Australia
[13] Univ Hosp Pisa, Obes & Lipodystrophy Ctr, Pisa, Italy
[14] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[15] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[16] Univ Washington, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
623
引用
收藏
页码：S457 / S459
页数：3
相关论文
共 50 条
  • [41] THE PROGNOSTIC VALUE OF FATTY LIVER INDEX FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS
    Siafi, Eirini
    Andrikou, Ioannis
    Thomopoulos, Costas
    Konstantinidis, Dimitrios
    Manta, Eleni
    Polyzos, Dimitrios
    Tatakis, Fotis
    Zammanis, Ioannis
    Drogkaris, Sotirios
    Kariori, Maria
    Kakouri, Niki
    Liatakis, Ioannis
    Filippou, Christina
    Tsioufi, Konstantinos
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E124 - E124
  • [42] THE PROGNOSTIC VALUE OF FATTY LIVER INDEX FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS
    Siafi, Eirini
    Andrikou, Ioannis
    Thomopoulos, Costas
    Konstantinidis, Dimitrios
    Manta, Eleni
    Polyzos, Dimitrios
    Tatakis, Fotis
    Zammanis, Ioannis
    Drogkaris, Sotirios
    Kariori, Maria
    Kakouri, Niki
    Liatakis, Ioannis
    Filippou, Christina
    Tsioufi, Konstantinos
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E124 - E124
  • [43] Cardiovascular disease in patients with non-alcoholic fatty liver disease
    Kantartzis, Konstantinos
    Stefan, Norbert
    ANNALS OF GASTROENTEROLOGY, 2012, 25 (03): : 276 - 277
  • [44] Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
    Ishido, Shun
    Tamaki, Nobuharu
    Takahashi, Yuka
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Keitoku, Taisei
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Kurosaki, Masayuki
    Izumi, Namiki
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [45] Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
    Shun Ishido
    Nobuharu Tamaki
    Yuka Takahashi
    Naoki Uchihara
    Keito Suzuki
    Yuki Tanaka
    Haruka Miyamoto
    Michiko Yamada
    Hiroaki Matsumoto
    Tsubasa Nobusawa
    Taisei Keitoku
    Kenta Takaura
    Shohei Tanaka
    Chiaki Maeyashiki
    Yutaka Yasui
    Kaoru Tsuchiya
    Hiroyuki Nakanishi
    Masayuki Kurosaki
    Namiki Izumi
    BMC Gastroenterology, 23
  • [46] CHARACTERISTICS OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH SEVERE OBESITY: INSIGHTS FROM 3077 CONSECUTIVE LIVER BIOPSIES
    Singh, Tavankit
    Mehta, Neal
    Vozzo, Catherine F.
    Schauer, Philip R.
    McCullough, Arthur
    Aminian, Ali
    GASTROENTEROLOGY, 2019, 156 (06) : S1256 - S1256
  • [47] Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart
    Cusi, Kenneth
    Godinez Leiva, Eddison
    CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (06) : 364 - 366
  • [48] Surgical Management of Obesity in Patients with Morbid Obesity and Nonalcoholic Fatty Liver Disease
    Dixon, John B.
    CLINICS IN LIVER DISEASE, 2014, 18 (01) : 129 - +
  • [49] Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
    Kumar, Mavidi Sunil
    Singh, Akanksha
    Jaryal, Ashok Kumar
    Ranjan, Piyush
    Deepak, K. K.
    Sharma, Sanjay
    Lakshmy, R.
    Pandey, R. M.
    Vikram, Naval K.
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2016, 2016
  • [50] Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial
    Abbas Ali Sangouni
    Azadeh Nadjarzadeh
    Fatemeh Sadat Rohani
    Fatemeh Sharuni
    Zahra Zare
    Shahab Rahimpour
    Hashem Hojjat
    Mahdieh Hosseinzadeh
    European Journal of Nutrition, 2024, 63 : 95 - 105
12345